keliximab
Sign in to saveKeliximab is a monoclonal antibody for the treatment of severe chronic asthma. It suppresses the immune reaction by binding to white blood cells via the protein CD4. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
~1 min read
Article
1 sectionsContents
- References
Keliximab is a monoclonal antibody for the treatment of severe chronic asthma. It suppresses the immune reaction by binding to white blood cells via the protein CD4. The drug is a chimeric antibody from Macaca irus and Homo sapiens.
== References ==
Connections
fusion protein
Entity
human
Entity
monoclonal antibody
Entity
lumiliximab
Entity
medication
Entity
primate
Entity
asthma
Entity
immunity
Entity
digital object identifier
Entity
white blood cell
Entity
antibody
Entity
Q180686
Entity
antigen
Entity
T-lymphocytes
Entity
CAS Registry Number
Entity
interferon
Entity
crab-eating macaque
Entity
thalidomide
Entity
Anatomical Therapeutic Chemical Classification System
Entity
intravenous infusion and defusion
Entity